The hepatitis E virus (HEV) is the fifth known form of viral hepatitis and was first recognized
as the cause of an epidemic of unexplained acute hepatitis in the early 1980s. Globally, it is …

Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging
infectious diseases; its efficacy was later associated with the evidence that polyclonal …

Purpose of review We aim to provide the readers an up-to-date knowledge of the structure,
epidemiology, and transmission followed by a detailed discussion on testing, diagnostics …

While the majority of worldwide hepatitis E viral (HEV) infections that occur in people are
from contaminated water or food sources, there has also been a steadily rising number of …

HEV is the most causative agent of acute viral hepatitis globally. HEV causes acute, chronic,
and extrahepatic manifestations. Chronic HEV infection develops in immunocompromised …

Abstract Hepatitis E Virus (HEV) infection is a worldwide disease and the primary cause of
acute viral hepatitis in the world with an estimated 20 million cases every year and 70 000 …

The term hepatitis E refers to clinical consequences associated with infection with hepatitis E
virus (HEV), the most recently discovered of the 5 currently known hepatotropic viruses. The …

Blood transfusions are vital components of modern medical treatment to which there is no
viable alternative despite efforts to create artificial blood. Each year thousands of lives are …

While there is no proven treatment available for coronavirus disease 2019 (COVID-19),
convalescent plasma (CP) may provide therapeutic relief as the number of cases escalate …

Background Hepatitis E virus (HEV) is usually transmitted by faecal–oral route. Recent
reports have documented HEV viraemia in donated blood units and HEV transmission …